Bexsero (BEX-sare-roe, meningococcal B vaccine) will be the first meningococcal vaccine to cover serogroup B

Bexsero (BEX-sare-roe, meningococcal B vaccine) will be the first meningococcal vaccine to cover serogroup B in Canada.

There are 12 serogroups of Neisseria meningitides...but most cases of meningitis are caused by serogroups A, B, C, Y, and W-135.

Currently all provinces and territories routinely immunize young children against serogroup C (Menjugate, etc). Some also routinely immunize adolescents against serogroup C or give a quadrivalent combo of serogroups A, C, Y, and W-135 (Menactra, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote